Is Amgen Stock a Buy Now?
fool.com
news
2022-10-20 12:45:00

Shares of Amgen (AMGN -1.56%) have been rising of late after a recent analyst upgrade generated some bullishness around the biotech company. Year to date, the stock is now up 12%, soundly outperforming the S&P 500, which has fallen 22% over the same period.Â 
What's all the excitement about? Should you buy the stock as it is climbing, or is Amgen's valuation due to fall back down? Let's take a look.
Analyst expectations are mixed
Morgan Stanley upgraded Amgen's stock last week, setting a price target of $279 for the company, noting that its weight-loss treatment, AMG 133, has been demonstrating positive results.
